223 related articles for article (PubMed ID: 24920818)
41. Induction of a major histocompatibility complex class I-restricted cytotoxic T-lymphocyte response to a highly conserved region of human immunodeficiency virus type 1 (HIV-1) gp120 in seronegative humans immunized with a candidate HIV-1 vaccine.
Johnson RP; Hammond SA; Trocha A; Siliciano RF; Walker BD
J Virol; 1994 May; 68(5):3145-53. PubMed ID: 7908700
[TBL] [Abstract][Full Text] [Related]
42. Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120.
Esser MT; Mori T; Mondor I; Sattentau QJ; Dey B; Berger EA; Boyd MR; Lifson JD
J Virol; 1999 May; 73(5):4360-71. PubMed ID: 10196334
[TBL] [Abstract][Full Text] [Related]
43. HIV-1 gp41 Residues Modulate CD4-Induced Conformational Changes in the Envelope Glycoprotein and Evolution of a Relaxed Conformation of gp120.
Keller PW; Morrison O; Vassell R; Weiss CD
J Virol; 2018 Aug; 92(16):. PubMed ID: 29875245
[TBL] [Abstract][Full Text] [Related]
44. Increased Epitope Complexity Correlated with Antibody Affinity Maturation and a Novel Binding Mode Revealed by Structures of Rabbit Antibodies against the Third Variable Loop (V3) of HIV-1 gp120.
Pan R; Qin Y; Banasik M; Lees W; Shepherd AJ; Cho MW; Kong XP
J Virol; 2018 Apr; 92(7):. PubMed ID: 29343576
[TBL] [Abstract][Full Text] [Related]
45. Allosteric induction of the CD4-bound conformation of HIV-1 Gp120.
Roitburd-Berman A; Dela G; Kaplan G; Lewis GK; Gershoni JM
Retrovirology; 2013 Dec; 10():147. PubMed ID: 24304511
[TBL] [Abstract][Full Text] [Related]
46. Monoclonal antibodies raised against covalently crosslinked complexes of human immunodeficiency virus type 1 gp120 and CD4 receptor identify a novel complex-dependent epitope on gp 120.
DeVico AL; Rahman R; Welch J; Crowley R; Lusso P; Sarngadharan MG; Pal R
Virology; 1995 Aug; 211(2):583-8. PubMed ID: 7544051
[TBL] [Abstract][Full Text] [Related]
47. Co-receptor Binding Site Antibodies Enable CD4-Mimetics to Expose Conserved Anti-cluster A ADCC Epitopes on HIV-1 Envelope Glycoproteins.
Richard J; Pacheco B; Gohain N; Veillette M; Ding S; Alsahafi N; Tolbert WD; Prévost J; Chapleau JP; Coutu M; Jia M; Brassard N; Park J; Courter JR; Melillo B; Martin L; Tremblay C; Hahn BH; Kaufmann DE; Wu X; Smith AB; Sodroski J; Pazgier M; Finzi A
EBioMedicine; 2016 Oct; 12():208-218. PubMed ID: 27633463
[TBL] [Abstract][Full Text] [Related]
48. HLA class II antigens and the HIV envelope glycoprotein gp120 bind to the same face of CD4.
Houlgatte R; Scarmato P; el Marhomy S; Martin M; Ostankovitch M; Lafosse S; Vervisch A; Auffray C; Platier-Tonneau D
J Immunol; 1994 May; 152(9):4475-88. PubMed ID: 7512597
[TBL] [Abstract][Full Text] [Related]
49. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C
Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249
[TBL] [Abstract][Full Text] [Related]
50. Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding.
Sattentau QJ; Moore JP
J Exp Med; 1991 Aug; 174(2):407-15. PubMed ID: 1713252
[TBL] [Abstract][Full Text] [Related]
51. A synthetic conformational epitope from the C4 domain of HIV Gp120 that binds CD4.
Robey FA; Harris-Kelson T; Robert-Guroff M; Batinić D; Ivanov B; Lewis MS; Roller PP
J Biol Chem; 1996 Jul; 271(30):17990-5. PubMed ID: 8663408
[TBL] [Abstract][Full Text] [Related]
52. Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding.
Clayton LK; Sieh M; Pious DA; Reinherz EL
Nature; 1989 Jun; 339(6225):548-51. PubMed ID: 2543930
[TBL] [Abstract][Full Text] [Related]
53. Human immunodeficiency virus type 1 evades T-helper responses by exploiting antibodies that suppress antigen processing.
Chien PC; Cohen S; Tuen M; Arthos J; Chen PD; Patel S; Hioe CE
J Virol; 2004 Jul; 78(14):7645-52. PubMed ID: 15220439
[TBL] [Abstract][Full Text] [Related]
54. CD4+ T-Cell Epitope Prediction by Combined Analysis of Antigen Conformational Flexibility and Peptide-MHCII Binding Affinity.
Charles T; Moss DL; Bhat P; Moore PW; Kummer NA; Bhattacharya A; Landry SJ; Mettu RR
Biochemistry; 2022 Aug; 61(15):1585-1599. PubMed ID: 35834502
[TBL] [Abstract][Full Text] [Related]
55. Characterization of CD4-induced epitopes on the HIV type 1 gp120 envelope glycoprotein recognized by neutralizing human monoclonal antibodies.
Xiang SH; Doka N; Choudhary RK; Sodroski J; Robinson JE
AIDS Res Hum Retroviruses; 2002 Nov; 18(16):1207-17. PubMed ID: 12487827
[TBL] [Abstract][Full Text] [Related]
56. Characterization of a discontinuous epitope of the HIV envelope protein gp120 recognized by a human monoclonal antibody using chemical modification and mass spectrometric analysis.
Hager-Braun C; Hochleitner EO; Gorny MK; Zolla-Pazner S; Bienstock RJ; Tomer KB
J Am Soc Mass Spectrom; 2010 Oct; 21(10):1687-98. PubMed ID: 20434359
[TBL] [Abstract][Full Text] [Related]
57. Induction of HIV-1 envelope (gp120)-specific cytotoxic T lymphocyte responses in mice by recombinant CHO cell-derived gp120 is enhanced by enzymatic removal of N-linked glycans.
Doe B; Steimer KS; Walker CM
Eur J Immunol; 1994 Oct; 24(10):2369-76. PubMed ID: 7523139
[TBL] [Abstract][Full Text] [Related]
58. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
[TBL] [Abstract][Full Text] [Related]
59. Oligomerization of CD4 is required for stable binding to class II major histocompatibility complex proteins but not for interaction with human immunodeficiency virus gp120.
Sakihama T; Smolyar A; Reinherz EL
Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6444-8. PubMed ID: 7604010
[TBL] [Abstract][Full Text] [Related]
60. Elicitation of broadly reactive antibodies against glycan-modulated neutralizing V3 epitopes of HIV-1 by immune complex vaccines.
Kumar R; Tuen M; Liu J; Nàdas A; Pan R; Kong X; Hioe CE
Vaccine; 2013 Nov; 31(46):5413-21. PubMed ID: 24051158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
